Tranylcypromine is a non-hydrazine monoamine oxidase inhibitor for the treatment of symptoms of depressive illness especially where phobic symptoms are present or where treatment with other types of anti-depressants has failed. It is not recommended for mild depressive states resulting from temporary situational difficulties.
Tranylcypromine is indicated for the treatment of Major Depressive Episodes in adult patients when treatment with other types of anti-depressant medication has failed.